We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
CONMED
CNMD
$1.47B
| $5.12M | 0.01% |
63,969
-67,381
| -51% | -$6.01M |
|
927
KKR & Co
KKR
$92.3B
| $5.12M | 0.01% |
50,900
+29,100
| +133% | +$2.68M |
|
928
Methode Electronics
MEI
$592M
| $5.09M | 0.01% |
417,722
+174,621
| +72% | +$3.3M |
|
929
DigitalBridge
DBRG
$2.95B
| $5.08M | 0.01% |
263,716
+43,740
| +20% | +$823K |
|
930
PUT
MP Materials
MP
$9.1B
| $5.07M | 0.01% |
+354,400
| New | +$5.61M |
|
931
BlueLinx
BXC
$706M
| $5.06M | 0.01% |
38,872
-38,758
| -50% | -$4.56M |
|
932
Grupo Cibest SA
CIB
$21.1B
| $5.06M | 0.01% |
147,746
+80,756
| +121% | +$2.62M |
|
933
DNOW Inc
DNOW
$2.99B
| $5.05M | 0.01% |
332,116
-195,214
| -37% | -$2.36M |
|
934
Sphere Entertainment
SPHR
$5.73B
| $5.04M | 0.01% |
+102,643
| New | +$4.11M |
|
935
Healthcare Services Group
HCSG
$1.53B
| $5.02M | 0.01% |
402,583
-175,595
| -30% | -$1.95M |
|
936
Kadant
KAI
$3.99B
| $5.02M | 0.01% |
15,301
-28,710
| -65% | -$8.66M |
|
937
MidCap Financial Investment
MFIC
$804M
| $5M | 0.01% |
332,329
+23,385
| +8% | +$332K |
|
938
BILL Holdings
BILL
$4.78B
| $5M | 0.01% |
72,694
+49,094
| +208% | +$3.43M |
|
939
SPDR Gold Trust
GLD
$141B
| $4.99M | 0.01% |
+24,280
| New | +$4.66M |
|
940
Viking Therapeutics
VKTX
$4B
| $4.99M | 0.01% |
60,846
-58,100
| -49% | -$2.59M |
|
941
Welltower
WELL
$171B
| $4.98M | 0.01% |
+53,302
| New | +$4.83M |
|
942
APi Group
APG
$18B
| $4.98M | 0.01% |
190,050
+84,150
| +79% | +$1.96M |
|
943
Arcus Biosciences
RCUS
$3.64B
| $4.97M | 0.01% |
263,277
+150,204
| +133% | +$2.6M |
|
944
Phathom Pharmaceuticals
PHAT
$692M
| $4.96M | 0.01% |
467,448
+200,591
| +75% | +$1.7M |
|
945
PUT
JetBlue
JBLU
$2.29B
| $4.96M | 0.01% |
669,000
-3,963,600
| -86% | -$24.6M |
|
946
Douglas Dynamics
PLOW
$1.02B
| $4.96M | 0.01% |
205,495
+161,170
| +364% | +$4.08M |
|
947
Synaptics
SYNA
$4.15B
| $4.94M | 0.01% |
50,605
-48,415
| -49% | -$5.09M |
|
948
Bankunited
BKU
$3.36B
| $4.92M | 0.01% |
175,800
+119,900
| +214% | +$3.35M |
|
949
Camping World
CWH
$653M
| $4.92M | 0.01% |
176,509
-284,258
| -62% | -$7.33M |
|
|
DCPH
950
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $4.91M | 0.01% |
312,426
-95,506
| -23% | -$1.47M |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.